NZ706108A - Topical ketoprofen composition - Google Patents

Topical ketoprofen composition

Info

Publication number
NZ706108A
NZ706108A NZ706108A NZ70610813A NZ706108A NZ 706108 A NZ706108 A NZ 706108A NZ 706108 A NZ706108 A NZ 706108A NZ 70610813 A NZ70610813 A NZ 70610813A NZ 706108 A NZ706108 A NZ 706108A
Authority
NZ
New Zealand
Prior art keywords
composition
topical
ketoprofen composition
topical ketoprofen
oxybenzone
Prior art date
Application number
NZ706108A
Other languages
English (en)
Inventor
Servet Buyuktimkin
Nadir Buyuktimkin
James L Yeager
Original Assignee
Achelios Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achelios Therapeutics Inc filed Critical Achelios Therapeutics Inc
Publication of NZ706108A publication Critical patent/NZ706108A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NZ706108A 2012-09-27 2013-09-24 Topical ketoprofen composition NZ706108A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261706163P 2012-09-27 2012-09-27
US13/826,706 US8822537B2 (en) 2012-09-27 2013-03-14 Topical ketoprofen composition
PCT/US2013/061403 WO2014052313A1 (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Publications (1)

Publication Number Publication Date
NZ706108A true NZ706108A (en) 2018-03-23

Family

ID=50339476

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ706108A NZ706108A (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Country Status (13)

Country Link
US (1) US8822537B2 (enExample)
EP (1) EP2900231B1 (enExample)
JP (1) JP6238991B2 (enExample)
KR (1) KR102184245B1 (enExample)
AU (1) AU2013323766B2 (enExample)
BR (1) BR112015006790B1 (enExample)
CA (1) CA2885619C (enExample)
ES (1) ES2902850T3 (enExample)
IL (1) IL237810B (enExample)
MX (1) MX373916B (enExample)
NZ (1) NZ706108A (enExample)
RU (1) RU2652345C2 (enExample)
WO (1) WO2014052313A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2767646C (en) 2009-07-10 2019-01-29 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
JP2017536421A (ja) * 2014-12-01 2017-12-07 アケリオス セラピューティクス，インコーポレーテッド 片頭痛及び疼痛に関連する状態を処置するための方法及び組成物
CN108348774A (zh) 2015-08-03 2018-07-31 哈佛大学校长及研究员协会 带电离子通道阻断剂及其应用
WO2017106714A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
KR20190003535A (ko) * 2016-03-31 2019-01-09 스마테크 토피칼, 인코포레이티드 전달 시스템
CA3079530A1 (en) * 2017-11-30 2019-06-06 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Stable liquid composition of ketoprofen, salts and enantiomers thereof
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129131A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113924094A (zh) 2019-03-11 2022-01-11 诺西恩医疗公司 酯取代的离子通道阻滞剂及其使用方法
JP7678757B2 (ja) 2019-03-11 2025-05-16 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
AU2020379828A1 (en) * 2019-11-06 2022-04-28 Smartech Topical, Inc. Topical formulations of cyclooxygenase inhibitors and their use
EP4054586A4 (en) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7708777B2 (ja) 2020-03-11 2025-07-15 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US5863527A (en) * 1996-09-04 1999-01-26 The Proctor & Gamble Company Personal care compositions
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
JP2004532254A (ja) * 2001-05-30 2004-10-21 ザ プロクター アンド ギャンブル カンパニー 結合剤としてアルファ−ベータ−不飽和エステルを含む局所化粧品用組成物
DE10141258B4 (de) * 2001-08-23 2004-09-23 Beiersdorf Ag Kosmetische und dermatologische Zubereitung und ihre Verwendung
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
ITFI20030070A1 (it) * 2003-03-18 2004-09-19 Berlin Chemie Ag Formulazioni topiche stabilizzate contenenti ketoprofene
EP1488787A1 (en) * 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
ATE534373T1 (de) * 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
US7928144B2 (en) * 2004-06-15 2011-04-19 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory and analgesic preparation for external use
PL1872796T3 (pl) * 2005-02-25 2012-01-31 Hisamitsu Pharmaceutical Co Preparat przezskórny do stosowania zewnętrznego zawierający niesteroidowy lek przeciwzapalny/przeciwbólowy
US8080237B2 (en) * 2005-09-15 2011-12-20 Benjamin Sredni Use of tellurium compounds for protection from ultra-violet radiation
EP2010132A1 (en) * 2006-04-18 2009-01-07 DSMIP Assets B.V. Cosmetic compositions comprising salicylic acid and ascorbic acid
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8409600B2 (en) * 2009-01-23 2013-04-02 J&E Solutions, Llc Methods for prevention and/or treatment of capsular contracture
WO2011075688A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions

Also Published As

Publication number Publication date
CA2885619A1 (en) 2014-04-03
ES2902850T3 (es) 2022-03-30
KR102184245B1 (ko) 2020-11-30
HK1212898A1 (en) 2016-06-24
MX373916B (es) 2020-07-10
CA2885619C (en) 2020-09-08
BR112015006790A2 (pt) 2017-07-04
JP6238991B2 (ja) 2017-11-29
MX2015004006A (es) 2015-10-29
US20140088195A1 (en) 2014-03-27
IL237810B (en) 2018-06-28
EP2900231B1 (en) 2021-11-03
BR112015006790B1 (pt) 2022-05-31
EP2900231A1 (en) 2015-08-05
US8822537B2 (en) 2014-09-02
AU2013323766B2 (en) 2017-08-17
JP2015531374A (ja) 2015-11-02
RU2015115723A (ru) 2016-11-20
AU2013323766A1 (en) 2015-04-09
RU2652345C2 (ru) 2018-04-25
KR20150074009A (ko) 2015-07-01
EP2900231A4 (en) 2016-03-02
WO2014052313A1 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
NZ706108A (en) Topical ketoprofen composition
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
MX374915B (es) Uso de excipientes polimericos para liofilizacion o congelacion de particulas.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
MX373228B (es) Formulaciones piretroides.
IN2014DN06104A (enExample)
NZ606589A (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof
IN2014DN09228A (enExample)
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
EP4556457A3 (en) Methods and compositions for potentiating stem cell therapies
GB2502032A (en) Vitamin D composition
NZ628433A (en) Chitosan-derived compositions
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
UA115357C2 (uk) Похідні піридин-4-ілу
TWD168756S (zh) 方向盤之部分
AR086682A1 (es) Formulacion de aripiprazol liofilizado
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
AR093632A1 (es) Tratamiento de cafe soluble
IN2014KN02914A (enExample)
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
WO2015013709A3 (en) Compositions for treating skin thickening
WO2014146111A3 (en) Analgesic compounds and methods of use
WO2012125552A3 (en) Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery
CL2012003250A1 (es) Uso de un galactolipido en combinacion con acido ascorbico y/o un derivado del mismo que sirve para proteger una composicion contra la oxidacion; metodo para la preparacion de la composicion, composicion; y producto.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 SEP 2019 BY AJ PARK

Effective date: 20180921

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 SEP 2020 BY AJ PARK

Effective date: 20190920

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 SEP 2021 BY AJ PARK

Effective date: 20200826

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 SEP 2022 BY AJ PARK

Effective date: 20210910

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 SEP 2023 BY AJ PARK

Effective date: 20220803

LAPS Patent lapsed